Target intelligence / Profile preview

Host cellular antioxidant pathways

Molecular classification
Enzyme (e.g., superoxide dismutase, catalase, glutathione peroxidase), Transcription factor (e.g., NRF2, AP-1, NF-κB), Small molecule antioxidant (e.g., glutathione, vitamins C/E), Other (cellular pathways/regulatory networks)
01

Overview

Host cellular antioxidant pathways are integrated systems consisting of enzymatic and non-enzymatic processes that detoxify reactive oxygen and nitrogen species produced during normal metabolism or pathological states. These pathways include enzymes like superoxide dismutase, catalase, and glutathione peroxidase; transcription factors such as NRF2, NF-κB, and AP-1; and small molecule antioxidants like glutathione, vitamins C and E. By balancing the generation and removal of reactive species, these pathways sustain redox homeostasis, modulate cell signaling, and protect against oxidative damage to proteins, DNA, and lipids. Dysregulation or exhaustion of antioxidant defenses contributes to the development and progression of cancer, neurodegenerative disease, cardiovascular disorders, diabetes, and other pathologies.

Other names
antioxidant systemantioxidant pathwayscellular redox systemantioxidant defense systemredox homeostasis pathways
02

Mechanism of action

Free radical scavenging; Enzymatic detoxification of reactive oxygen species; Upregulation of antioxidant gene transcription via NRF2 pathway; Regeneration of oxidized cellular antioxidants

03

Biological functions

Maintenance of redox homeostasisProtection against oxidative and nitrosative stressRegulation of cell signalingRegulation of cell proliferation, apoptosis, inflammation, and immune response
04

Disease associations

CancerCardiovascular diseaseNeurodegenerative diseaseDiabetesInflammationInfectionAging-related disorders
05

Safety considerations

Over-suppression of oxidative signaling may impair immune response and physiological cell signalingAntioxidant supplementation may have pro-oxidant effects at high dosesChronic high-dose antioxidant therapy may be associated with increased risk for some diseases or interfere with anticancer treatments
06

Interacting drugs

N-acetylcysteine

4 more in the full profile.

07

Biomarkers

Reduced/oxidized glutathione ratio (GSH/GSSG)8-hydroxydeoxyguanosine (8-OHdG, marker of DNA oxidation)Malondialdehyde (MDA, marker of lipid peroxidation)Protein carbonyls

Beyond the preview

Go deeper on Host cellular antioxidant pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host cellular antioxidant pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call